ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,243.39
-0.65%
US Tech 100
17,986.40
-0.23%
Dow Jones
38,284.78
-1.04%
Brent Oil
78.315
-3.08%
Bitcoin
68,970.85
1.80%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Genelux Corporation (GNLX)

  7. Genelux Corporation (GNLX) News

GNLX

Genelux (GNLX)

Genelux Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNLX
DateTimeSourceHeadlineSymbolCompany
05/24/20245:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
05/24/20248:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
05/24/20248:00AMGlobeNewswire Inc.Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsNASDAQ:GNLXGenelux Corporation
05/23/20244:59PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
05/23/20244:01PMGlobeNewswire Inc.Genelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:GNLXGenelux Corporation
05/15/20245:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
05/09/20244:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
05/09/20244:25PMGlobeNewswire Inc.Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
05/09/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
04/01/20247:00AMGlobeNewswire Inc.Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GNLXGenelux Corporation
02/14/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GNLXGenelux Corporation
02/05/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
02/02/20244:39PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
02/02/20244:36PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GNLXGenelux Corporation
02/02/20244:06PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GNLXGenelux Corporation
12/18/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
12/15/20234:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
12/14/20238:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
12/14/20238:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
12/13/20234:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
12/13/20234:35PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
12/12/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
12/08/20235:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
12/07/20235:02PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
11/27/20237:00AMGlobeNewswire Inc.Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNASDAQ:GNLXGenelux Corporation
11/24/20231:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
11/22/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
11/17/20235:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
11/14/20235:50PMGlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
11/14/20234:24PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
 Showing the most relevant articles for your search:NASDAQ:GNLX

Your Recent History

BIT
F08869
Vontobel Financial Produ...
AMEX
WRND
IQ Global Equity R&D Lea...
LSE
CATH
Lyxor Msci Cath
COIN
ARGONUST
ArgonToken
NASDAQ
FEUZ
First Trust Eurozone Alp...
NASDAQ
FSVBXX
Vest Large Cap Deep Buff...
AMEX
NETL
Netlease Corporate Real ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved